DFW Capital Partners (“DFW”) announced today that it has completed an investment in WorldCare Clinical, LLC (“WorldCare”), a global imaging CRO. Aaron Timm, CEO of WorldCare Clinical since 2014, will continue to lead the company. This investment will accelerate WorldCare’s growth and delivery as it continues to expand upon its leading capabilities.
Jeff Kinell and Lori Wright, former senior executives in the clinical research industry and operating partners of DFW, will join the board of directors of WorldCare Clinical. Mr. Kinell was previously CEO of Bracket Global, a technology solutions provider for the clinical trial industry and CRI Lifetree, a clinical trials specialty site operator. Ms. Wright was previously CEO of Evolution Research Group, a leading independent clinical research site business and former portfolio company of DFW.
Mr. Timm commented, “Our goal at WorldCare Clinical is to advance clinical research by maximizing the precision and accuracy of central reviews of clinical trial data for the benefit of sponsors and patients. The WorldCare Clinical team and I are excited to work with the DFW team to achieve our goal.”
Brett Prager, Partner at DFW, added “DFW is thrilled to partner with Aaron and his team on the next phase of WorldCare’s growth. We are committed to investing in the continued excellence in delivery that the company brings to the clinical trial marketplace.”
About DFW Capital Partners
DFW Capital Partners is a private equity investment firm focused on lower middle-market companies. The firm concentrates on service companies, with an emphasis on healthcare and outsourced business and industrial support services. DFW has established a 20+ year track record of success in building leading companies. DFW is headquartered in Teaneck, New Jersey and maintains an office in Chevy Chase, Maryland.
About WorldCare Clinical, LLC
WorldCare Clinical is a global imaging CRO that employs scientific expertise, innovative technology, and operational excellence to maximize the precision and accuracy of blinded independent central review of Phase I – IV clinical trial data. The company has worked with thousands of sites in more than 70 countries. Originally founded in 1992 by the Massachusetts General Hospital (MGH) Department of Radiology, WorldCare continues to maintain a strategic relationship with the Harvard Hospital System as well as other leading academic institutions.